Barclays PLC Buys 35,967 Shares of Waters Co. (NYSE:WAT)

Barclays PLC boosted its holdings in Waters Co. (NYSE:WAT) by 42.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 121,243 shares of the medical instruments supplier’s stock after purchasing an additional 35,967 shares during the quarter. Barclays PLC owned about 0.20% of Waters worth $43,319,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. BlackRock Inc. increased its holdings in Waters by 1.4% in the third quarter. BlackRock Inc. now owns 5,737,944 shares of the medical instruments supplier’s stock worth $2,050,168,000 after purchasing an additional 80,183 shares in the last quarter. Principal Financial Group Inc. increased its holdings in Waters by 2.2% in the third quarter. Principal Financial Group Inc. now owns 81,739 shares of the medical instruments supplier’s stock worth $29,205,000 after purchasing an additional 1,747 shares in the last quarter. Progressive Investment Management Corp increased its holdings in Waters by 0.5% in the third quarter. Progressive Investment Management Corp now owns 22,262 shares of the medical instruments supplier’s stock worth $7,954,000 after purchasing an additional 104 shares in the last quarter. JustInvest LLC increased its holdings in Waters by 14.2% in the third quarter. JustInvest LLC now owns 1,838 shares of the medical instruments supplier’s stock worth $657,000 after purchasing an additional 228 shares in the last quarter. Finally, Ieq Capital LLC bought a new stake in Waters in the third quarter worth approximately $288,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

NYSE WAT opened at $333.73 on Friday. The company has a market cap of $20.37 billion, a price-to-earnings ratio of 29.93, a P/E/G ratio of 2.94 and a beta of 0.86. Waters Co. has a 52 week low of $258.91 and a 52 week high of $428.22. The business has a 50 day moving average price of $348.46 and a 200-day moving average price of $368.80. The company has a quick ratio of 1.89, a current ratio of 2.47 and a debt-to-equity ratio of 5.47.

Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, November 2nd. The medical instruments supplier reported $2.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.34 by $0.32. Waters had a return on equity of 271.71% and a net margin of 25.40%. The business had revenue of $659.23 million for the quarter, compared to analysts’ expectations of $652.28 million. During the same quarter in the previous year, the firm earned $2.16 earnings per share. On average, equities research analysts anticipate that Waters Co. will post 11 earnings per share for the current year.

In other Waters news, Director Edward Conard sold 4,000 shares of the company’s stock in a transaction dated Thursday, December 2nd. The stock was sold at an average price of $336.01, for a total value of $1,344,040.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 1.10% of the company’s stock.

About Waters

Waters Corp. is a specialty measurement company which engages in analytical workflow solutions involving liquid chromatography, mass spectrometry and thermal analysis innovations. It operates through the Waters and TA segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and related services.

Recommended Story: What is the Consumer Price Index (CPI)?

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.